Is Biora Therapeutics, Inc. (BIOR) a Buy, Sell, or Hold?
OTC : BIOR
Biora Therapeutics, Inc.
$0.22 USD
$0 (0.0%)
- Volume
- 169.45K
- Average Volume
- 60.81K
- Market Capitalization
- $994.99K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.38
- Year Low
- $0.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.30
Company Overview
OTC
Aditya Mohanty
Biotechnology
Healthcare
BIOR
58
US
USD
Liquidity Metrics
-0.47
0.30
0.30
0.24
0.00
Sales & Valuation
$4000
248.75
0.00
-0.02
-30.81
Profitability
-$78.7
-$124.12M
-3102875.00%
-3110600.00%
121.86%
-397.61%
P/E Metrics
0.00
0.00
0.00
Analyst Price Target & Rating
0/5
1 Analysts
%
Financial Health Scores
-109.16
4/9
-$114.56M
$14.5M
$121.13M
-$28.41M
Key Metrics (TTM)
$33.21M
8302.50
-0.29
0.30
121.86%
232.28%
-35766.74%
-4884.65%
75738 days
Company Executives
| Name | Title |
|---|---|
| Clarke Neumann | Senior Vice President, General Counsel & Secretary |
| Eric d'Esparbes | Chief Financial Officer |
| Aditya Mohanty | Chief Executive Officer & Director |
| James Knight | Head of Business Development |
| Kevin Howe | Senior Vice President of Strategic Operations |
| Paul Shabram | Head of Technical Operations |
Poll Results
No votes yet today — be the first to share your view!
About Biora Therapeutics, Inc. (OTC:BIOR) Stock
Biora Therapeutics, Inc. is a biotechnology company focused on developing cutting-edge oral biotherapeutic solutions. The company's core efforts involve two main therapeutic programs: Targeted Therapeutics: This program utilizes an advanced ingestible smart capsule designed to deliver medications precisely within the gastrointestinal (GI) tract. The aim is to significantly improve therapies for inflammatory bowel diseases. Systemic Therapeutics: Through a specialized ingestible capsule, this initiative provides a needle-free method for administering biotherapeutics directly into the intestinal lining, thereby promoting more effective systemic absorption throughout the body. Furthermore, Biora is actively developing diagnostic devices. These tools are engineered to better characterize the d ... igestive system and identify various GI conditions, such as small intestine bacterial overgrowth, by offering on-site diagnosis. Originally established in 2010 as Progenity, Inc., the company rebranded to Biora Therapeutics, Inc. in April 2022. This name change was made to reflect its concentrated strategic shift towards its therapeutics pipeline. Biora Therapeutics, Inc. is headquartered in San Diego, California.
Frequently Asked Questions
-
What is the current Biora Therapeutics, Inc. (BIOR) stock price?
-
Biora Therapeutics, Inc.(OTC:BIOR) stock price is $0.22 in the last trading session. During the trading session, BIOR stock reached the peak price of $0.3802 while $0.15 was the lowest point it dropped to. The percentage change in BIOR stock occurred in the recent session was 0.0% while the dollar amount for the price change in BIOR stock was $0.
-
BIOR's industry and sector of operation?
-
The OTC listed BIOR is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of BIOR?
-
Clarke Neumann | Senior Vice President, General Counsel & Secretary
Eric d'Esparbes | Chief Financial Officer
Aditya Mohanty | Chief Executive Officer & Director
James Knight | Head of Business Development
Kevin Howe | Senior Vice President of Strategic Operations -
How many employees does BIOR have?
-
Number of BIOR employees currently stands at 58. BIOR operates from 4330 La Jolla Village Drive, San Diego, CA 92122, US.
-
Link for BIOR official website?
-
Official Website of BIOR is: https://www.bioratherapeutics.com
-
How do I contact BIOR?
-
BIOR could be contacted at phone #855 293 2639 and can also be accessed through its website. BIOR operates from 4330 La Jolla Village Drive, San Diego, CA 92122, US.
-
How many shares of BIOR are traded daily?
-
The average number of BIOR shares traded daily for last 3 months was 60.81K.
-
What is the market cap of BIOR currently?
-
The market value of BIOR currently stands at $994.99K with its latest stock price at $0.22